Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma

This study is ongoing, but not recruiting participants.

Study NCT00458731 Information provided by M.D. Anderson Cancer Center

First Received: April 9, 2007 Last Updated: December 15, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2014 (Final data collection date for primary outcome measure)